Clinical trial No longer in our active list Interventional Ages 18 and up

Using a collagen matrix to treat gum recession

Official title: Coronally Advanced Flap With Xenogenic Collagen Matrix or Autogenous Connective Tissue Graft for the Treatment of Multiple Adjacent Gingival Recessions: a Randomized Controlled Trial

Run by University of Turin, Italy · NCT05693753 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new collagen treatment can help people with gum recession feel better compared to a traditional gum graft method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment40 (estimated)
SponsorUniversity of Turin, Italy
Academic / other
Locations1 site (Turin)
Trial IDNCT05693753 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with multiple adjacent teeth exhibiting specific types of gingival recessions.

Probably not a fit

Patients with systemic diseases affecting therapy outcomes, current smokers, or those with a history of periodontal surgery on the involved teeth may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of a xenogenic collagen matrix (XCM) compared to an autologous connective tissue graft (CTG) for treating multiple adjacent gingival recessions using a multiple coronally advanced flap technique (mCAF). The primary focus is on recession reduction, while secondary outcomes include changes in keratinized tissue width, probing pocket depth, and patient-reported outcomes such as pain and swelling. Participants will be monitored at 6 months and 1 year to assess the results of both treatment methods.

Why it matters

Potential benefit: If successful, this approach could provide a less invasive and more effective treatment option for patients with gum recession.

How similar studies have gone: Previous studies have shown promising results with similar approaches, but this specific comparison of XCM and CTG is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 18 years old and able to sign informed consent
* At least 2 adjacent teeth with RT1 and/or RT2 gingival recessions without interproximal exposure of the CEJ (interdental gingival recession), at least one with a depth of ≥2mm with indication for root coverage treatment
* A minimum of 4 adjacent teeth (including the ones to be treated) in the region of interest
* Available to attend study related procedures (including follow-up visits)

Exclusion Criteria:

* Systemic diseases/medications which could influence the outcome of the therapy (e.g., uncontrolled diabetes mellitus);
* Current smokers (self-reported, any type of smoking), users of chewing tobacco, and drug/alcohol abusers;
* Pregnant or nursing women;
* History of previous periodontal surgery (mucogingival or other) on the teeth to be included;
* Furcation involvement in the teeth to be included;
* Presence of severe tooth malposition, rotation or clinically significant extrusion in the teeth to be treated;
* Presence of fixed or removable prosthesis in the area to be treated

Where it's running

  • CIR Dental School
    Turin, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.